Nabsolute wins SelectUSA Tech APAC Summit Pitching Competition and announces expansion to USA in 2023
Nabsolute, together with officials fron the Royal Thai Embassy and representatives from Thai companies, joined 2023 SelectUSA Investment Summit

Nabsolute wins SelectUSA Tech APAC Summit Pitching Competition and announces expansion to USA in 2023

Nabsolute, the groundbreaking company developing nano-modified biopolymer delivery systems for healthcare products, has emerged victorious in the recent SelectUSA Tech APAC Summit Pitching Competition by US Department of Commerce. The company's revolutionary Hy-N Technology garnered significant attention, leading to an invitation to the main SelectUSA event and participation in the regional SelectUSA Tech pitching in the United States.

Established in 2020 as a spin-off from Chulalongkorn University, Nabsolute is a researchoriented company specializing in biomedical, polymer science, and healthcare business. The company's patented Hy-N Technology significantly enhances the efficacy, safety, and stability of cosmeceutical, food, and pharmaceutical products. This technology has undergone extensive scientific testing and has proven to be more effective, safer to use, and easier to synthesize. Already incorporated in products from several reputable domestic and international companies, Nabsolute's Hy-N Technology is transforming the healthcare sector.

Driven by a team of experts in biomedical, polymer science, and healthcare business, Nabsolute is dedicated to transforming impactful research into innovations that benefit society and improve people's health on a global scale. Nabsolute’s plan of US expansion has been supported by the Chula Global Innovation Club chaired by the Ambassador of Thailand to the United States of America, H.E. Mr. Tanee Sangrat, and the President of Chulalongkorn University, Prof. Bundhit Eau-arporn, and supported by partners from public and private organizations (i.e. BOI, NXPO, NIA, DEPA, DITP, DIP, Innospace, Thai startup, Techsauce, CU Enterprises). By participating in the SelectUSA event, the company aims to showcase its cutting-edge technology, share its vision, and explore opportunities for growth in the United States.

Nabsolute's future roadmap is ambitious and includes plans to expand to the USA in 2023. The company intends to strengthen its R&D capabilities, broaden its presence in the global market, and engage in fundraising activities in the biotech capital of the world. The United States provides a unique environment for Nabsolute to grow, with a thriving biotechnology ecosystem and access to resources that will help the company achieve its vision of revolutionizing the healthcare industry.

Nabsolute is grateful to the CU Innovation Hub, Chulalongkorn University's innovation platform, for its support in achieving this milestone. The Hub has successfully nurtured over 350 innovation-driven teams, with a combined valuation of over US$600 million, by fostering creativity and transforming research into practice.

With a commitment to excellence and a focus on research and innovation, Nabsolute's expansion to the USA represents a significant milestone in the company's journey. By establishing a strong presence in the United States, Nabsolute aims to cement its position as a global leader in healthcare product delivery systems, forging strategic partnerships and creating new opportunities for growth.

The company's participation in the SelectUSA event and its subsequent expansion to the USA will undoubtedly bring Nabsolute's technology to a wider audience, providing even more opportunities for collaboration and innovation in the biotechnology sector.

ABOUT NABSOLUTE

Nabsolute is a research-oriented company that develops delivery systems for healthcare products using nano-modified biopolymer. Founded in 2020 as a spin-off from Chulalongkorn University, Nabsolute's patented delivery system, "Hy-N Technology," improves efficacy and stability of cosmeceutical, food, and pharmaceutical products. The company's management team consists of experts in biomedical, polymer science, and healthcare business, who are dedicated to transforming impactful research into innovations that benefit society and improve people's health on a global scale.

For more information about Nabsolute and its innovative Hy-N Technology, please visit www.nabsolute.co.th or contact Assoc. Prof. Jittima Luckanagul, Ph.D., CTO/Co-Founder at [email protected]

要查看或添加评论,请登录

社区洞察

其他会员也浏览了